FDA questions third-party review of medical devices

NewsGuard 100/100 Score
The Wall Street Journal: The FDA is considering ending a program that allows medical-equipment makers to have their products reviewed by third-party companies instead of by FDA officials. "The agency's concerns about the third-party reviews come as the FDA is re-evaluating its entire device-approval process. In addition, the agency has recently announced tighter regulation of some machines that deliver radiation in the wake of reports of more than 300 cases of overdoses from CT scanners at four hospitals. ... Some third-party reviewers advertise speed and a friendlier process. Imaging devices such as X-ray and MRI machines have recently accounted for more than one-third of the products in the program. Makers of these machines like it because it can enable them to get pricey equipment on the market at least a month faster. ... The Web site for one of the third-party companies, Citech Inc., says it can get a product to market 'months sooner.' The site adds: 'Third-party review is also friendlier, less adversarial, than FDA review.'"

FDA says the original intent of the program was to save taxpayers' money (Mundy and Favole, 3/15).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Majority of AI clinical trials report positive outcomes, yet concerns over generalizability persist